We are live on ! Find out more
KALA icon

KALA BIO

22 hedge funds and large institutions have $294K invested in KALA BIO in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

10% more funds holding

Funds holding: 20 → 22 (+2)

40.46% less ownership

Funds ownership: 40.46% → 0% (-40%)

59% less capital inflows, than outflows

Capital inflows: $502K | Capital outflows: $1.23M

Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

KALA Hedge Fund Activity: Q1 2026 in Review

22 of the 8,244 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2026, worth a combined $294K — down 81% from $1.58M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new KALA positions and 7 closed out — a net gain of 3 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $159K. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $1M sold.

  • 22 institutional investors held KALA BIO (KALA) as of Q1 2026, up from 20 in Q4 2025.
  • Funds reported $294K of KALA BIO stock for Q1 2026, down 81% quarter-over-quarter.
  • 10 funds opened new KALA BIO positions in Q1 2026 and 7 closed out, a net change of +3 holders.
  • The largest KALA BIO buyer in Q1 2026 was Renaissance Technologies, an estimated $159K added.
  • The largest KALA BIO seller in Q1 2026 was Baker Bros. Advisors, an estimated $1M sold.

Based on aggregated 13F filings for Q1 2026.